Earlier this year, the FDA called on the life sciences and healthcare industry to design and deliver pilot projects for an electronic, interoperable system that can identify and trace prescription drugs as they are distributed across the United States in support of the DSCSA. Systech partnered with several industry innovators to respond to the FDA’s proposal including RxTransparent, T-Systems, FarmaTrust, CryptoWerk and CalQLogic.
According to the FDA, the interoperability requirement is set to go into effect in 2023 and its primary objective is to be able electronically track the movement of each product as it passes through multiple stakeholders along the supply chain. This requires an elevated level of technological efficiency that’s currently not in place. This explains why the deadline isn’t for years to come – but pharma should be hesitant to procrastinate. Preparation starts now.
Dubbed the “Optimal Solutions” team, each partner serves a different purpose in the proposal. In this podcast we sit down with Joe Lipari, Director of Cloud Products, to examine Systech’s role in the development of the group submission, how together the team aims to make the pharmaceutical supply chain more interoperable and efficient, and the status of the overall project.
Ready to learn more? Systech Radio is available for streaming on Google Podcasts, iTunes and Spotify!
